Development
The Clorox Company
CLX
$122.17
$0.590.49%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 3.47% | -0.09% | 3.97% | 0.89% | -0.21% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.47% | -0.09% | 3.97% | 0.89% | -0.21% |
| Cost of Revenue | -5.82% | -7.25% | -1.71% | -2.30% | 2.11% |
| Gross Profit | 19.79% | 12.92% | 14.15% | 6.60% | -4.04% |
| SG&A Expenses | 16.95% | 14.55% | 14.41% | 7.36% | -2.89% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 41.67% | 23.08% | 63.64% | -51.16% | -42.86% |
| Total Operating Expenses | 0.68% | -1.14% | 2.89% | -0.15% | 0.16% |
| Operating Income | 28.98% | 10.17% | 13.62% | 11.27% | -3.46% |
| Income Before Tax | -72.70% | -71.93% | -60.79% | -77.55% | 79.69% |
| Income Tax Expenses | -50.77% | -57.72% | -43.38% | -58.93% | 103.13% |
| Earnings from Continuing Operations | -79.10% | -76.14% | -65.82% | -82.01% | 73.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -30.00% | -30.00% | -33.33% | -11.11% | -11.11% |
| Net Income | -81.61% | -78.77% | -67.75% | -83.84% | 76.11% |
| EBIT | 28.98% | 10.17% | 13.62% | 11.27% | -3.46% |
| EBITDA | 23.12% | 9.25% | 11.53% | 9.39% | -1.71% |
| EPS Basic | -81.82% | -78.89% | -67.88% | -83.75% | 75.40% |
| Normalized Basic EPS | 32.83% | 13.80% | 17.88% | 12.81% | -2.63% |
| EPS Diluted | -82.26% | -79.40% | -68.26% | -84.03% | 76.22% |
| Normalized Diluted EPS | 32.98% | 14.00% | 18.22% | 13.35% | -2.62% |
| Average Basic Shares Outstanding | 0.47% | 0.44% | 0.39% | 0.09% | -0.50% |
| Average Diluted Shares Outstanding | 0.40% | 0.29% | 0.11% | -0.38% | -0.68% |
| Dividend Per Share | 1.70% | 1.71% | 1.72% | 1.72% | 2.40% |
| Payout Ratio | 4.56% | 3.82% | 2.17% | 5.34% | -0.42% |